Patents
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
04/2005
04/07/2005US20050075352 3,4-Dihydro-(1H)-quinazolin-2-ones and their use as CSBP/p38 kinase inhibitors
04/07/2005US20050075348 Functionalized heterocycles as modulators of chemokine receptor function and methods of use therefor
04/07/2005US20050075347 For the prevention and/or therapy of ischaemia and reperfusion damage
04/07/2005US20050075344 Melanocortin receptor agonists
04/07/2005US20050075339 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
04/07/2005US20050075334 Novel compounds
04/07/2005US20050075333 Substituted quinazolines and pyrimidinopyridines useful for the treatment of inflammatory and immunoregulatory disorders and diseases, such as multiple sclerosis, rheumatoid arthritis and type I diabetes; compounds modulate the expression and/or function of a chemokine receptor
04/07/2005US20050075332 Tricyclic compounds with antiviral activity
04/07/2005US20050075331 Viricides for infections caused by an RNA-containing virus; enzyme inhibitors for a hepatitis C virus (HCV) polymerase; inhibiting HCV viral replication; liver cirrhosis; e. g., 1-[2-(1-cyclohexen-1-yl)ethyl]-3-(1,1- ioxido-4H-1,2,4-benzo- thiadiazin-3-yl)-4-hydroxy-1,8-naphthyridin-2(1H)-one
04/07/2005US20050075330 Dipeptidyl peptidase inhibitors
04/07/2005US20050075328 Such as (2'-methoxy-[1,1'-biphenyl]-4-yl)-(5H,11H-pyrrolo[2,1-c][1,4]benzodiazepin-10-yl)methanone; for treatment of diabetes insipidus, nocturnal enuresis, nocturia, urinary incontinence, or hemophilia
04/07/2005US20050075325 Selective D1/D5 receptor antagonists for the treatment of obesity and CNS disorders
04/07/2005DE19845402B4 Mit Heterocyclen substituierte Propanolaminderivate, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung -Containing heterocycles substituted with Propanolaminderivate, process for their production, medicaments containing these compounds and their use
04/07/2005DE10123587B4 Cyanoanthranylamid-Derivate und deren Verwendung als Arzneimittel Cyanoanthranylamid derivatives and their use as medicaments
04/07/2005CA2744997A1 C-met modulators and method of use
04/07/2005CA2540518A1 Compounds and compositions as protein kinase inhibitors
04/07/2005CA2540355A1 Phenylene derivative having tetrazole ring or thiazolidinedione ring
04/07/2005CA2540031A1 Macrocyclic inhibitors of hepatitis c virus ns3 serine protease
04/07/2005CA2540019A1 Quinazoline derivatives as antiproliferative agents
04/07/2005CA2540008A1 Quinazoline derivatives
04/07/2005CA2539823A1 Hemiasterlin derivatives and uses thereof
04/07/2005CA2539235A1 5-arylpyrimidines as anticancer agents
04/07/2005CA2538263A1 Substituted sulfonamide-indole-2-carboxylic acid derivatives as pai-1 inhibitors
04/07/2005CA2537004A1 Therapeutic agents useful for treating pain
04/06/2005EP1520856A1 Androgen receptor agonist
04/06/2005EP1520472A2 Herbicidal compositions comprising pyridoyl-1,3-cyclodiones
04/06/2005EP1520452A2 Electronic devices made with electron transport and/or anti-quenching layers
04/06/2005EP1520308A2 Polymeric charge transport compositions and electronic devices made with such compositions
04/06/2005EP1520305A2 Charge transport compositions and electronic devices made with such compositions
04/06/2005EP1519935A2 Charge transport compositions comprising fluorinated phenanthroline derivatives
04/06/2005EP1519921A2 Substituted anthranilic amide derivatives and methods of use
04/06/2005EP1519918A1 Peptide inhibitors of smac protein binding to inhibitor of apoptosis proteins (iap)
04/06/2005EP1519915A2 Tricyclic steroid hormone nuclear receptor modulators
04/06/2005EP1519727A1 4-(4-methylpiperazin-1-ylmethyl)-n- 4-methyl-3-(4-pyridin-3- yl)pyrimidin-2-ylamino)phenyl -benzamide for treating pulmon ary fibrosis
04/06/2005EP1414817B1 substituted isoindoles and the use thereof
04/06/2005EP1353909B1 8-substituted-2,6-methano-3-benzazocines and 3-substituted morphinanes as opioidreceptor binding agents
04/06/2005EP1218357B1 Quinazoline derivatives
04/06/2005EP1212486B1 Chlorohydrin and cationic compounds having high affinity for pulp or paper
04/06/2005EP1202975B1 Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade
04/06/2005EP1077700B1 BENZIMIDAZOLE DERIVATIVES AS MODULATORS OF IgE
04/06/2005EP1020459B1 Cis-disubstituted aminocycloalkyl-pyrrolidine derivatives
04/06/2005EP0984930B1 2-indolinone derivatives as modulators of protein kinase activity
04/06/2005EP0920426B9 New thiazole derivatives with phosphodiesterase-inhibiting effect
04/06/2005CN1604968A Methods to treat diabetes and related conditions based on polymorphisms in the TCF-1 gene
04/06/2005CN1604894A 经取代的苯基衍生物 Substituted phenyl derivatives
04/06/2005CN1604893A Cyclic amine compounds
04/06/2005CN1604776A 4-4-alkoxy-3-hydroxyphenyl-2-pyrrolidone derivatives as pde-4 inhibitors for the treatment of neurological syndromes
04/06/2005CN1603291A Novel intermediates useful for the preparation of antihistaminic piperidine derivatives
04/06/2005CN1195762C Novel 2-(iminomethyl) amino-phenyl derivatives, preparation, application as medicines and compositions containing same
04/06/2005CN1195752C Processes for producing 7-isoindolinequinolonecarboxylic derivatives and intermediates therefor, solts of 7-isoindo-linequinolonecarboxylic acid, hydrates thereof, and composition contg. same
04/06/2005CN1195745C Antiviral macrocyclic compounds
04/06/2005CN1195741C Pyrimidinone compounds, pharmaceutical compositions containing the compounds and the process for preparing the same
04/06/2005CN1195740C Pharmaceutical compositions comprising 2-quinolones
04/06/2005CN1195737C HIV proteinase inhibitor
04/06/2005CN1195736C Gatrokinetic monocyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives
04/06/2005CN1195522C Benzodiazepine derivatives
04/05/2005US6875872 Omeprazole, or salt thereof; antisecretory agents, antiulcer agents; skin disorders
04/05/2005US6875871 Oxazolidinone photoaffinity probes
04/05/2005US6875870 Discoloration inhibition, colorfastness for candle wax; polymers
04/05/2005US6875831 Mono and multifunctional alkoxyamines for the preparation of functionalized macromers
04/05/2005US6875789 Pyrazole-derived kinase inhibitors and uses thereof
04/05/2005US6875788 Non-insulin dependent diabetes, antidiabetic agents, dietetics, antilipemic agents, anticholesterol agents, cardiovascular disorders
04/05/2005US6875779 Cyclooxygenase inhibitor
04/05/2005US6875778 Substituted with pyridinylmethyl-, oxazolylmethyl-, imidazolylmethyl-, or thiazolylmethyl- groups
04/05/2005US6875777 Compounds
04/05/2005US6875776 Antihistamines; antiallergens; antiinflammatory agents; autoimmune diseases; rheumatic diseases
04/05/2005US6875770 Antiinflamamtory agents; side effect reduction
04/05/2005US6875764 Urea and thiourea compounds useful for treatment of coccidiosis
04/05/2005US6875761 Certain 1,3-disubstituted isoquinoline derivatives
04/05/2005CA2339621C 2-substituted-1-piperidyl benzimidazole compounds as orl1-receptor agonists
04/05/2005CA2270086C New benzothiophene, benzofuranic and indolic derivatives, their preparation process and pharmaceutical compositions containing them
04/05/2005CA2226671C 4-mercaptopyrrolidine derivatives as farnesyl transferase inhibitors
04/05/2005CA2166975C Benzoxazinone and benzopyrimidinone piperidinyl tocolytic oxytocin receptor antagonists
04/05/2005CA2092694C Use of pyridylmethylsulphinyl-1h-benzimidazole derivates in the treatment of illnesses caused by helicobacter bacteria
03/2005
03/31/2005WO2005028471A1 Synthesis of quinoline 5-carboxamides useful for the preparation of pde iv inhibitors
03/31/2005WO2005028470A1 Quinazoline derivatives
03/31/2005WO2005028469A1 Quinazoline derivatives
03/31/2005WO2005028468A1 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1h-benzimidazol-5-carbonyl)-pyridine-2-yl-amino]-propionic acid ethyl ester methane sulphonate and use thereof as a medicament
03/31/2005WO2005028467A1 Antibacterial 3,5-diaminopiperidine-substitute aromatic and heteroaromatic compounds
03/31/2005WO2005028466A1 Benzimidazolone and quinazolinone derivatives as agonists on human orl1 receptors
03/31/2005WO2005028452A1 Substituted triazole derivatives as oxytocin antagonists
03/31/2005WO2005028451A1 Tetrahydroquinoxalines and their use as m2 acetylcholine receptor agonists
03/31/2005WO2005028448A1 Benzyl-benzimidazolyl derivatives
03/31/2005WO2005028447A1 Benzimidazole derivates: preparation and pharmaceutical applications
03/31/2005WO2005028444A1 1,4-disubstituted isoquinilone derivatives as raf-kinase inhibitors useful for the treatment of proliferative diseases
03/31/2005WO2005028443A2 Protein tyrosine kinase enzyme inhibitors
03/31/2005WO2005028440A1 Novel gamma secretase inhibitors
03/31/2005WO2005028436A2 Thalidomide analogs as tnf-alpha modulators
03/31/2005WO2005027823A2 3-heterocyclyl-indole derivatives as inhibitors of glycogen synthase kinase-3 (gsk-3)
03/31/2005WO2005014581A3 Lanthanide complexes preparation and uses thereof
03/31/2005WO2005005394A3 Thiophenylaminoimidazolines as prostaglandin i2 antagonists
03/31/2005WO2004108133A3 Modulators of vr1 receptor
03/31/2005WO2004103973A8 Phenyl quinolines and their use as estrogen receptor modulators
03/31/2005WO2004094379A3 3-phenyl-4- (pyrimidin-2-yl) -6- (piperidin-4-yl) derivatives and related compounds as tnf-alpha and il-1 inhibitors for the treatment of inflammations
03/31/2005WO2004089307A3 Acylated spiropiperidine derivatives as melanocortin-4 receptor agonists
03/31/2005WO2004084824A3 Biaryl substituted 6-membered heterocyles as sodium channel blockers
03/31/2005WO2004018454A8 A method for the purification of lansoprazole
03/31/2005WO2004008837A3 Novel benzohydrazide derivatives as herbicides and desiccant compositions contaning them
03/31/2005WO2003091243A8 Ester derivatives of a decahydroisoquinoline-3-carboxylic acid as analgestics
03/31/2005US20050070720 11-Beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia